Who We Are

About RIVVE Life Science

RIVVE Life Science is a regional pharmaceutical commercialization partner enabling international companies to successfully enter and expand across the GCC and Middle East.

The company provides a full-service commercialization model covering regulatory, market access, medical affairs, marketing, sales, and distribution management through a coordinated regional platform.

RIVVE operates a no-partner local-entity-required model, allowing partners to access multiple GCC markets without establishing their own legal presence.

Headquartered in Dubai, RIVVE Life Science is designed for pharmaceutical and biotechnology companies without regional infrastructure, RIVVE acts as a single strategic partner managing end-to-end market entry and commercialization execution across the UAE, Saudi Arabia, and broader GCC region

Who We Are

  • To help global pharmaceutical companies successfully enter and expand in the GCC & Middle East through a flexible partnership model combining regulatory expertise, market access capabilities, and commercial execution.

  • To be the leading GCC commercialization partner for specialty medicines, delivering successful launches and sustainable, compliant growth.

  • RIVVE Life Science represents a new model of pharmaceutical market entry in Saudi , UAE and the CGG region combining regulatory, medical, and commercial execution into a single outsourced platform.

    Our structure allows Full-Service Market Entry & Commercialization Across GCC for international companies to work with one strategic partner while RIVVE Life Science executes :

    • Local distribution

    • Regulatory submissions

    • Market access strategy

    • Medical engagement

    • Commercial launch execution

    This model significantly reduces complexity & time to market for our partners.

  • Regulatory Strategy & Market Entry

    RIVVE supports partners in navigating the regulatory frameworks of GCC

    • Regulatory strategy development

    • Dossier submission and lifecycle management

    • Pricing and reimbursement support

    Commercial Launch & Market Development

    RIVVE designs and executes tailored commercialization strategies to ensure successful product launches.

    • Launch planning and execution

    • Field Force strategy and management

    • KOL engagement and scientific promotion

    • Commercial strategy and forecasting

    Medical Affairs & Scientific Engagement

    Our medical strategy ensures strong clinical credibility and physician engagement.

    Activities include:

    • Medical science liaison (MSL) engagement

    • Scientific education programs

    • Advisory boards and investigator relationships

    Market Access & Reimbursement

    Understanding the payer landscape is critical in GCC markets.

    Our expertise in :

    • Health authority engagement

    • Pharmacoeconomic value communication

    • Pricing strategy and reimbursement negotiation

    Distribution Network Management

    We manage local distribution through our trusted best-in-class licensed distributors in each country.

    • Full reach to private & Government market

    • Efficient product importation and supply

    • Compliance with local regulations

  • RIVVE Life Science operates through flexible partnership models designed around partner needs.

    Possible structures include:

    • Master distribution models

    • Commercialization partnerships

    • Launch support agreements

    • Product licensing

    Our objective is to create long-term partnerships focused on compliant sustainable growth and patient access.

    GCC represents one of the fastest-growing pharmaceutical markets globally, driven by healthcare investment, regulatory transformation, and increasing demand for innovative therapies. However, successful market entry requires more than regulatory approval—it demands a strong commercialization strategy tailored to the region.

    Companies like Newbridge Pharmaceuticals and GAIA Healthcare have demonstrated the value of integrated commercialization models combining market access, distribution, and commercial execution.

    Emerging partners such as RIVVE Life Science are further evolving this model by offering agile, partnership-driven approaches designed for both established pharmaceutical companies and emerging biotech firms.

  • Primary markets include:

    • Saudi Arabia

    • United Arab Emirates

    • Kuwait

    • Qatar

    • Bahrain

    • Oman

    RIVVE also supports expansion into the Middle East & North Africa (MENA) region.

  • RIVVE prioritizes innovative therapies in areas of high unmet medical need, including:

    • Pediatrics

    • Neurology

    • Psychiatry

    • Immunology

    • Oncology

    • Rare diseases

    • Dermatology

    • Specialty Care

Key Therapeutic Expertise

  • Dermatology

  • Immunology

  • Neurology

  • Oncology

  • Psychiatry

  • Pediatrics

  • Specialty Care

Our Capabilities

  • RIVVE Life Science executes full regulatory activities

    Regulatory strategy development

    Dossier submission and lifecycle management

    Pricing and reimbursement support

  • RIVVE Life Science executes full commercial activities

    Launch planning and execution

    Field Force strategy and management

    KOL engagement and scientific promotion

    Commercial strategy and forecasting

  • RIVVE Life Science executes full medical activities

    Medical science liaison (MSL) engagement

    Scientific education programs

    Advisory boards and investigator relationships

  • RIVVE Life Science executes full market access activities

    Health Authority engagement

    Pharmacoeconomic value communication

    Pricing strategy and reimbursement negotiation

  • RIVVE Life Science executes full distribution activities

    Trusted best-in-class licensed distributors in each country

    Full reach to private & Government

    Efficient product importation and supply

    Compliance with local regulations

Why Partner With RIVVE

  • One Regional Partner

  • Deep GCC Regulatory & Access Expertise

  • Flexible Partnership Models

  • Strong Distributors & Stakeholders Network

  • Focus on Specialty Medicines

Our Commitment

At RIVVE Life Science, we believe that every patient deserves access to the best available therapies

By partnering with global pharmaceutical innovators, we work to ensure that life-changing medicines reach patients in the Middle East faster and more effectively

Our Story

RIVVE represents the idea of flow, connection, and momentum in bringing innovative medicines to patients.

The name evokes the image of a river a powerful channel that connects distant sources to the places where life depends on them. In the same way, RIVVE Life Science acts as the channel that connects global pharmaceutical innovation with patients and healthcare systems across the GCC and Middle East.

  • Many breakthrough therapies are developed globally, but reaching patients in emerging markets often requires navigating complex regulatory systems, fragmented distribution networks, and diverse healthcare environments. RIVVE was created to Simplify The Journey.

  • RIVVE Life Science was founded by industry experts with extensive experience in pharmaceutical commercialization, market access, and regional market development across the Middle East.

    Through years of working with international pharmaceutical companies, regional distributors, healthcare authorities, and key opinion leaders, the founders recognized a recurring challenge:

    Global companies needed a trusted regional partner capable of navigating the complexity of the Middle East while executing high-quality launches and compliant sustainable market growth.

  • RIVVE Life Science is a regional pharmaceutical commercialization partner enabling international companies to successfully enter and expand across the GCC and Middle East.

    By combining deep regional expertise, strong healthcare stakeholder relationships, and a flexible commercialization model, The company provides a full-service commercialization model covering regulatory, market access, medical affairs, marketing, sales, and distribution management through a coordinated regional platform.

    RIVVE operates a no-partner local-entity-required model, allowing partners to access multiple GCC markets without establishing their own legal presence.

    Designed for pharmaceutical and biotechnology companies without regional infrastructure, RIVVE acts as a single strategic partner managing end-to-end market entry and commercialization execution across the UAE, Saudi Arabia, and broader GCC region.

  • The double “V” in RIVVE symbolizes:

    • Value for partners

    • Voice for patients

    • Velocity in bringing therapies to market

    At its core, RIVVE is built around one belief:

    “Innovation should move fast to where patients need it most”

OUR FOUNDERS

RIVVE Life Science was founded by pharmaceutical industry professionals with extensive experience across commercialization, market access, regulatory strategy, and regional market development in the GCC and Middle East.

The company is led by Mostafa Nagib, who brings senior leadership experience including General Manager responsibilities across Saudi Arabia and North & Central Africa, along with broader regional and global exposure. Throughout his career, he has worked closely with international pharmaceutical companies, regional distributors, healthcare authorities, and leading medical experts, supporting the successful introduction and growth of innovative therapies in complex healthcare markets.

Recognizing the challenges global pharmaceutical companies face when entering the region, the founders established RIVVE Life Science to provide a full-service commercialization platform capable of bridging global innovation with regional execution.

From day one, RIVVE Life Science has been built with a core team of experienced professionals across commercial, regulatory, medical, and market access functions, each bringing approximately 15–25 years of GCC regional experience. This ensures that partners benefit from deep local expertise combined with coordinated, high-quality execution across multiple markets.

RIVVE Life Science operates a no-partner local-entity-required model, enabling international pharmaceutical companies to access GCC markets through a single, integrated partner managing regulatory, medical, market access, and commercial activities.

The company’s vision is to combine deep regional expertise, global compliance standards, strong healthcare relationships, and flexible partnership models to support international pharmaceutical innovators in achieving successful market entry and sustainable growth across the Middle East.

Let’s Work Together